enprofylline has been researched along with Action Tremor in 4 studies
enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Enprofylline is a novel xanthine derivative with negligible adenosine antagonizing ability." | 6.66 | Additive bronchodilator effects of terbutaline and enprofylline in asthma. ( Lunell, E; Rasmussen, JB, 1987) |
| "Enprofylline is a novel xanthine derivative with negligible adenosine antagonizing ability." | 2.66 | Additive bronchodilator effects of terbutaline and enprofylline in asthma. ( Lunell, E; Rasmussen, JB, 1987) |
| " Neither at the low nor at the high dosage (2 +/- 4 mg/kg), giving plasma concentrations of 8." | 2.65 | Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung disease. ( Andersson, KE; Lunell, E; Persson, CG; Svedmyr, N, 1982) |
| "Enprofylline is a potent bronchodilating xanthine derivative that has been shown to have little or no ability to antagonize adenosine in a variety of cell types." | 2.65 | A novel bronchodilator xanthine apparently without adenosine receptor antagonism and tremorogenic effect. ( Andersson, KE; Lunell, E; Persson, CG; Svedmyr, N, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lunell, E | 3 |
| Svedmyr, N | 2 |
| Andersson, KE | 2 |
| Persson, CG | 2 |
| Laursen, LC | 1 |
| Johannesson, N | 1 |
| Søndergaard, I | 1 |
| Weeke, B | 1 |
| Rasmussen, JB | 1 |
4 trials available for enprofylline and Action Tremor
| Article | Year |
|---|---|
Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung disease.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Forced Expiratory Volume; Hemodynamics; Humans; Lung | 1982 |
A novel bronchodilator xanthine apparently without adenosine receptor antagonism and tremorogenic effect.
Topics: Adult; Aged; Asthma; Blood Pressure; Bronchodilator Agents; Clinical Trials as Topic; Double-Blind M | 1983 |
Maximally effective plasma concentrations of enprofylline and theophylline during constant infusion.
Topics: Adult; Aged; Bronchodilator Agents; Female; Forced Expiratory Volume; Humans; Infusions, Parenteral; | 1984 |
Additive bronchodilator effects of terbutaline and enprofylline in asthma.
Topics: Adult; Aged; Asthma; Blood Pressure; Bronchodilator Agents; Drug Synergism; Female; Forced Expirator | 1987 |